Latest period
$86.48B
YoY change
+32.0%
5Y CAGR
+85.3%
Peak year (2025)
$85.37B
Latest annual
$85.37B
Total Assets history chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: $85.37B
Total Assets growth chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: +32.0%
Total Assets history table for Novo Nordisk (NVO) from 1985 to 2025
| 2025 | $85.37B | +32.0% | +$20.71B | ||
| 2024 | $64.67B | +38.9% | +$18.10B | ||
| 2023 | $46.56B | +34.0% | +$11.83B | ||
| 2022 | $34.74B | +16.7% | +$4.98B | ||
| 2021 | $29.75B | +660.7% | +$25.84B | ||
| 2020 | $3.91B | +38.1% | +$1.08B | ||
| 2019 | $2.83B | -83.4% | −$14.18B | ||
| 2018 | $17.01B | +3.1% | +$514.36M | ||
| 2017 | $16.50B | +19.5% | +$2.69B | ||
| 2016 | $13.80B | +3.2% | +$431.21M | ||
| 2015 | $13.37B | +6.8% | +$847.14M | ||
| 2014 | $12.52B | -3.7% | −$476.98M | ||
| 2013 | $13.00B | +11.9% | +$1.38B | ||
| 2012 | $11.62B | +3.0% | +$333.99M | ||
| 2011 | $11.28B | +2.3% | +$256.36M | ||
| 2010 | $11.03B | +4.6% | +$488.38M | ||
| 2009 | $10.54B | +10.7% | +$1.02B | ||
| 2008 | $9.52B | +1.8% | +$163.99M | ||
| 2007 | $9.36B | +18.3% | +$1.45B | ||
| 2006 | $7.91B | +18.9% | +$1.26B | ||
| 2005 | $6.65B | -3.3% | −$224.43M | ||
| 2004 | $6.88B | +17.9% | +$1.04B | ||
| 2003 | $5.83B | — | — | ||
| 2002 | — | — | — | ||
| 2001 | — | — | — | ||
| 2000 | — | — | — | ||
| 1999 | — | — | — | ||
| 1998 | — | — | — | ||
| 1997 | — | — | — | ||
| 1996 | — | — | — | ||
| 1995 | — | — | — | ||
| 1994 | — | — | — | ||
| 1993 | — | — | — | ||
| 1992 | — | — | — | ||
| 1991 | — | — | — | ||
| 1990 | — | — | — | ||
| 1989 | — | — | — | ||
| 1988 | — | — | — | ||
| 1987 | — | — | — | ||
| 1986 | — | — | — | ||
| 1985 | — | — | — |
- 2025$85.37B+32.0%
- 2024$64.67B+38.9%
- 2023$46.56B+34.0%
- 2022$34.74B+16.7%
- 2021$29.75B+660.7%
- 2020$3.91B+38.1%
- 2019$2.83B-83.4%
- 2018$17.01B+3.1%
- 2017$16.50B+19.5%
- 2016$13.80B+3.2%
- 2015$13.37B+6.8%
- 2014$12.52B-3.7%
- 2013$13.00B+11.9%
- 2012$11.62B+3.0%
- 2011$11.28B+2.3%
- 2010$11.03B+4.6%
- 2009$10.54B+10.7%
- 2008$9.52B+1.8%
- 2007$9.36B+18.3%
- 2006$7.91B+18.9%
- 2005$6.65B-3.3%
- 2004$6.88B+17.9%
- 2003$5.83B—
- 2002——
- 2001——
- 2000——
- 1999——
- 1998——
- 1997——
- 1996——
- 1995——
- 1994——
- 1993——
- 1992——
- 1991——
- 1990——
- 1989——
- 1988——
- 1987——
- 1986——
- 1985——
Total Assets values are taken from Novo Nordisk's reported balance sheets (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts converted to USD using IAS 21 average exchange rates (P&L / cash flow) or closing rates (balance sheet). Originally filed in DKK.
About Total Assets at Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's latest reported total assets is $86.48B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Novo Nordisk (NVO) total assets is 542.90B DKK – grew 16.6% year-over-year.
Across 2020–2025 (5 years), Novo Nordisk total assets produced a CAGR of +86.9% – sustaining 6 straight years of year-over-year growth.
Across the available history, total assets reached its high of 542.90B DKK in 2025 and its low of 7.36B DKK in 1985.
Novo Nordisk Total Assets by Year
Novo Nordisk Total Assets 2025: $85.37B
In 2025, Novo Nordisk reported total assets of 542.90B DKK ($85.37B), grew 16.6% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk Total Assets 2024: $64.67B
Novo Nordisk total assets in 2024 was 465.80B DKK ($64.67B), surged 48.1% from 2023.
Novo Nordisk Total Assets 2023: $46.56B
2023's total assets for Novo Nordisk came in at 314.49B DKK ($46.56B), surged 30.4% from 2022.
Novo Nordisk Total Assets 2022: $34.74B
Novo Nordisk posted total assets of 241.26B DKK ($34.74B) in 2022, grew 24.0% from 2021.
Novo Nordisk Total Assets 2021: $29.75B
Novo Nordisk total assets in 2021 was 194.51B DKK ($29.75B).
See more financial history for Novo Nordisk (NVO).
Sector peers by Total Assets
Healthcare peers of Novo Nordisk (NVO), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $110.34B | |
| $90.59B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $110.34B
- $90.59B
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation